Navigation Links
Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
Date:8/19/2007

Oncomine and Oncomine Concepts Map Integral in Expression and Association

Analyses

ANN ARBOR, Mich., Aug. 2 /PRNewswire/ -- Building on an earlier study that used Oncomine(TM) to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. today report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).

(Logo: http://www.newscom.com/cgi-bin/prnh/20070213/NYTU093LOGO )

Tomlins et al. queried the Oncomine database to determine the tissue specificity of three of the new fusion gene partners, demonstrating that two new partners are prostate cancer specific while the third partner is a generally over-expressed 'house-keeping' gene. In addition, Oncomine Concepts Map was applied to test for similarities between the set of genes regulated by ETV1 with sets of genes related to other biological concepts. This analysis revealed a clear association between ETV1 activation and cellular invasion, a hallmark of cancer.

Oncomine, a dynamic repository that combines rich data, sophisticated analysis, and responsive user interface, empowers oncology research by bringing data analysis tools to a large cancer gene expression database, which includes data from 20,000+ microarray experiments curated from 300+ independent studies. Oncomine Concepts Map, an extension of Oncomine, is a compilation of nearly 8,000 Oncomine cancer gene signatures together with 11,500 gene, protein, drug, and pathway signatures collected from the literature and other public sources.

"This study marks an important advance in our understanding of the molecular basis of prostate cancer. Oncomine again proved invaluable in examining the expression of genes in cancer, and in this case aided in the characterization of new sub-types of prostate cancer," said Dan Rhodes, Ph.D., co-founder and Chief Science Officer of Compendia Bioscience. "The authors went on to show that one of the new subtypes is unlikely to respond to conventional anti-androgen therapy, and another may be adversely affected by standard therapies. This strongly suggests that using this type of molecular information to distinguish patient populations will have important clinical implications."

About Compendia Bioscience, Inc.

Compendia Bioscience is dedicated to harnessing the global collection of high throughput molecular data to provide researchers with the data and analysis tools necessary to validate biomarker and gene target discoveries, better understand mechanisms of disease, and optimize clinical outcomes.

About Oncomine(TM)

Oncomine(TM) combines a rapidly growing compendium of 20,000+ cancer transcriptome profiles with a sophisticated analysis engine and a powerful web application for data mining and visualization. Oncomine facilitates rapid and reliable biomarker and therapeutic target discovery, validation, and prioritization.

About Oncomine(TM) Concepts Map

Oncomine Concepts Map is licensed to commercial users as part of the Oncomine Concepts Edition and the Oncomine Enterprise Edition. Visit http://www.compendiabio.com for more information. An academic preview edition is available to academic and non-profit researchers at http://www.oncomine.org.


'/>"/>
SOURCE Compendia Bioscience, Inc.

Copyright©2007 PR Newswire.

Related medicine technology :

1. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
2. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
3. Protox Announces Positive Clinical Data from Prostate Cancer Study
4. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
5. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
6. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
7. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
8. Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
9. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
10. Quest PharmaTechs Prostate Cancer Program Update
11. Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
Breaking Medicine News(10 mins):